Cognition Genetic Report from SelfDecode

The report is generated by imputation over millions of genetic variants rather than direct clinical-grade genotyping. SelfDecode itself warns that imputation is much less accurate for rare SNPs and that results should not be relied on for high-impact variants such as APOE - a direct caveat on the product's Alzheimer's-risk use.

The report's headline areas - cognitive decline risk and neurodegenerative disease predisposition - match the Alzheimer's question directly. But the company's own warning against relying on its imputation for APOE-class variants materially weakens it as an Alzheimer's-risk product.

Thirty-two genetic results across cognitive decline, memory, reaction time, problem solving, and creativity, plus 50 DNA-based recommendations, give broad cognitive coverage. It includes no APOE result reliable enough for risk use and no amyloid or tau blood biomarkers.

No standalone price is published for this report - generating it requires purchasing a separate SelfDecode DNA kit, and the report page does not state the kit price or the subscription renewal terms, so cost cannot be assessed against a confirmed figure.

Conclusions are written in plain language, a sample report can be viewed before purchase, and the page advises sharing results with a doctor. No genetic counselor is included with the report.

The sample report and the imputation accuracy caveats are disclosed on the page, and scientific references are claimed. The full cost picture - kit price plus renewal terms - is not stated on the report page itself.

Collection is an at-home buccal swab with a prepaid return label, and results arrive in 3 to 6 weeks. Access requires buying the DNA kit first, adding a step and an unstated cost before the report exists.

The page states HIPAA and GDPR compliance, says DNA data is not sold to or shared with third parties, and offers deletion on request - a clearly stated privacy posture for a genetic product.